Medicare Enrolled
Dr. Srikanth Reddy, M.D.
Internal Medicine · Antioch, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reddy
Dr. Srikanth Reddy is an internal medicine specialist in Antioch, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 41,553 Medicare services across 2,609 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reddy received a total of $30,971 from 104 pharmaceutical and/or device companies across 1071 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in CA
$30,971 industry payments
Medicare Practice Summary
Medicare Utilization ↗41,553
Medicare services
Top 1% in CA for internal medicine
2,609
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,308 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 7,680 | $18 | $65 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,350 | $0 | $7 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
7,200 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,180 | $6 | $29 |
| MRI contrast dye injection (gadobutrol) | 3,075 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,020 | $6 | $47 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,550 | $0 | $7 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,370 | $1 | $90 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,079 | $8 | $32 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
951 | $8 | $17 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
595 | $14 | $83 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
516 | $94 | $862 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
433 | $30 | $140 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
389 | $116 | $347 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
345 | $83 | $355 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
325 | $76 | $252 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
304 | $165 | $464 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
230 | $140 | $635 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
203 | $54 | $248 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
197 | $6 | $333 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
186 | $1 | $8 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
143 | $20 | $86 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
129 | $66 | $295 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
112 | $1 | $16 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
102 | $29 | $143 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 102 | $288 | $1,138 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
100 | $1,737 | $6,779 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
90 | $16 | $92 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
70 | $1 | $32 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
69 | $69 | $307 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
62 | $3 | $15 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
55 | $325 | $1,367 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
52 | $182 | $911 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
41 | $4 | $21 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
38 | $153 | $552 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
34 | $72 | $182 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
33 | $22 | $109 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
29 | $114 | $356 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $136 | $459 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
23 | $100 | $251 |
| New patient office visit, complex (60-74 min) | 18 | $205 | $599 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
17 | $346 | $2,598 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $93 | $295 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
11 | $68 | $231 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.4% high complexity
87.9% medium
9.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$30,971
Total received (2018-2024)
Avg $4,424/year across 7 years
Top 4% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
104
Companies
1,071
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,066 (74.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,123 (23.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$782 (2.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,375
2023
$5,320
2022
$4,002
2021
$3,245
2020
$1,725
2019
$8,238
2018
$2,065
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$2,433
AstraZeneca Pharmaceuticals LP
$479
PFIZER INC.
$375
Novartis Pharmaceuticals Corporation
$338
Merck Sharp & Dohme LLC
$255
E.R. Squibb & Sons, L.L.C.
$216
Astellas Pharma US Inc
$199
Janssen Biotech, Inc.
$198
Regeneron Healthcare Solutions, Inc.
$144
GlaxoSmithKline, LLC.
$140
US Oncology Corporate, Inc.
$126
PROGENICS PHARMACEUTICALS, INC.
$107
Coherus Biosciences Inc.
$99
Celgene Corporation
$96
Daiichi Sankyo Inc.
$82
SpringWorks Therapeutics, Inc.
$81
Takeda Pharmaceuticals U.S.A., Inc.
$80
JAZZ PHARMACEUTICALS INC.
$74
ARRAY BIOPHARMA INC
$69
BeiGene USA, Inc.
$61
Gilead Sciences, Inc.
$58
Eisai Inc.
$56
Aveo Pharmaceuticals, Inc.
$55
GENZYME CORPORATION
$52
Kyowa Kirin, Inc.
$47
Incyte Corporation
$41
Geron Corporation
$33
Genmab U.S., Inc.
$32
Alexion Pharmaceuticals, Inc.
$31
Genentech USA, Inc.
$30
Agios Pharmaceuticals, Inc.
$29
Lilly USA, LLC
$29
Deciphera Pharmaceuticals Inc.
$28
ADC Therapeutics America, Inc.
$25
TAIHO ONCOLOGY, INC.
$25
Pharmacosmos Therapeutics Inc.
$24
SERVIER PHARMACEUTICALS LLC
$21
Azurity Pharmaceuticals, Inc.
$21
Spectrum Pharmaceuticals Inc.
$20
Cardinal Health 414 LLC
$20
Kite Pharma, Inc.
$17
RECORDATI_RARE_DISEASES_INC.
$13
Dexcom, Inc.
$13
Top 3 companies account for 51.6% of 2024 payments
All-time payments by company (2018-2024) ›
McKesson Specialty Care Distribution, LLC
$4,690
ABBVIE INC.
$2,830
AstraZeneca Pharmaceuticals LP
$1,987
E.R. Squibb & Sons, L.L.C.
$1,490
PFIZER INC.
$1,482
Novartis Pharmaceuticals Corporation
$1,478
Janssen Biotech, Inc.
$1,427
Amgen Inc.
$1,050
Astellas Pharma US Inc
$987
Seagen Inc.
$836
Celgene Corporation
$686
Takeda Pharmaceuticals U.S.A., Inc.
$673
Merck Sharp & Dohme Corporation
$637
Pharmacyclics LLC, An AbbVie Company
$617
Daiichi Sankyo Inc.
$606
Merck Sharp & Dohme LLC
$548
Lilly USA, LLC
$513
Genentech USA, Inc.
$509
GlaxoSmithKline, LLC.
$459
GENZYME CORPORATION
$342
Bayer HealthCare Pharmaceuticals Inc.
$341
Kite Pharma, Inc.
$340
Regeneron Healthcare Solutions, Inc.
$324
ADC Therapeutics America, Inc.
$267
Boehringer Ingelheim Pharmaceuticals, Inc.
$232
Puma Biotechnology, Inc.
$226
Incyte Corporation
$224
EISAI INC.
$203
Eisai Inc.
$195
Pharmacyclics LLC, an AbbVie Company
$186
JAZZ PHARMACEUTICALS INC.
$176
RefleXion Medical, Inc.
$175
Gilead Sciences, Inc.
$165
Ethicon Inc.
$159
Myovant Sciences Inc.
$156
Foundation Medicine, Inc.
$153
Karyopharm Therapeutics Inc.
$152
Sirtex Medical Inc
$148
Tactile Systems Technology Inc
$136
Pharmacosmos Therapeutics Inc.
$130
US Oncology Corporate, Inc.
$126
Coherus Biosciences Inc.
$121
BeiGene USA, Inc.
$119
Clovis Oncology, Inc.
$111
ARRAY BIOPHARMA INC
$110
PROGENICS PHARMACEUTICALS, INC.
$107
CTI BioPharma Corp.
$105
EMD Serono, Inc.
$99
Alexion Pharmaceuticals, Inc.
$99
Acrotech Biopharma LLC
$96
TESARO, Inc.
$94
Seattle Genetics, Inc.
$92
Rigel Pharmaceuticals, Inc.
$85
SpringWorks Therapeutics, Inc.
$81
Octapharma USA, Inc.
$70
INSYS Therapeutics Inc
$62
SOBI, INC
$61
Kyowa Kirin, Inc.
$60
Stemline Therapeutics Inc.
$55
Aveo Pharmaceuticals, Inc.
$55
PharmaEssentia USA Corporation
$53
Ipsen Biopharmaceuticals, Inc
$52
PUMA BIOTECHNOLOGY, INC.
$48
TAIHO ONCOLOGY, INC.
$47
Taiho Oncology, Inc.
$47
MorphoSys, US Inc.
$45
Lexicon Pharmaceuticals, Inc.
$41
Global Blood Therapeutics, Inc.
$39
TerSera Therapeutics LLC
$38
Dova Pharmaceuticals
$36
Blueprint Medicines Corporation
$34
APO-PHARMA USA, INC.
$34
Dendreon Pharmaceuticals LLC
$33
Geron Corporation
$33
Genmab U.S., Inc.
$32
Array BioPharma Inc.
$31
Insulet Corporation
$30
Agios Pharmaceuticals, Inc.
$29
Dexcom, Inc.
$29
AbbVie Inc.
$28
Mylan Institutional Inc.
$28
Deciphera Pharmaceuticals Inc.
$28
Sobi, Inc
$27
Sun Pharmaceutical Industries Inc.
$25
Amneal Pharmaceuticals LLC
$24
Biocompatibles, Inc.
$23
Janssen Scientific Affairs, LLC
$23
Ferring Pharmaceuticals Inc.
$23
SERVIER PHARMACEUTICALS LLC
$21
Azurity Pharmaceuticals, Inc.
$21
Exelixis Inc.
$21
Spectrum Pharmaceuticals Inc.
$20
Cardinal Health 414 LLC
$20
G1 Therapeutics, Inc.
$20
Myriad Genetic Laboratories, Inc.
$18
AMAG Pharmaceuticals, Inc.
$18
Secura Bio, Inc.
$17
Advanced Accelerator Applications
$16
Aurobindo Pharma USA, Inc.
$16
Shire North American Group Inc
$15
RECORDATI_RARE_DISEASES_INC.
$13
Novo Nordisk Inc
$12
West Therapeutics Development, LLC
$11
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 30.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CALQUENCE · CARVYKTI · CHANTIX · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Crysvita · DARZALEX · DOPTELET · Dexcom G6 Transmitter · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FERAHEME · FERRIPROX · FIRMAGON · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Flexitouch Plus · Folotyn · GAZYVA · GILOTRIF · HEMADY · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JARDIANCE · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KIT FOR THE PREPARATION OF LYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) · KYMRIAH · Kerendia · Kyprolis · LIBTAYO · LOKELMA · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · N/A · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONCASPAR · ONIVYDE · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Omnipod · Orserdu · Ozempic · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROVENGE · PYLARIFY · Padcev · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · REFLEXION MEDICAL RADIOTHERAPY SYSTEM · RETEVMO · ROLVEDON · RYBREVANT · RYTELO · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · STIOLTO RESPIMAT · SYLVANT · SYNDROS · Stivarga · Subsys · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · THERASPHERE-BIO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · VYXEOS · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
767
Per 100K population
66.0
County median income
$125,727
Nearest hospital
KAISER FOUNDATION HOSPITAL - ANTIOCH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Reddy performed 7,680 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $30,971 from 104 companies across 1,071 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other internal medicine physicians in Antioch?
Dr. Reddy's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Antioch
Browse internal medicine physicians in Antioch ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
McKesson Specialty Care Distribution, LLC Payments to Doctors
See all physicians who received payments from McKesson Specialty Care Distribution, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology